Egan, M. F., Mukai, Y., Voss, T., Kost, J., Stone, J., Furtek, C., . . . Michelson, D. (2019). Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer’s disease. Alzheimers Res Ther.
Styl ChicagoEgan, Michael F., et al. "Further Analyses of the Safety of Verubecestat in the Phase 3 EPOCH Trial of Mild-to-moderate Alzheimer’s Disease." Alzheimers Res Ther 2019.
Citace podle MLAEgan, Michael F., et al. "Further Analyses of the Safety of Verubecestat in the Phase 3 EPOCH Trial of Mild-to-moderate Alzheimer’s Disease." Alzheimers Res Ther 2019.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..